# Cardiopulmonary Bypass Prime Solution in Patients Undergoing Heart Valve Surgery

Study · id `cardio:ct-nct05223361` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05223361](<https://clinicaltrials.gov/study/NCT05223361>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05223361

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.

## Technical summary

Registry record NCT05223361. Randomized; triple masking; primary purpose prevention. Start 2016-04 (actual); primary completion 2021-04-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 120 participants (enrolled count; ClinicalTrials.gov record NCT05223361, source copy `cardio:ctgov-nct05223361-2022-02-03`, retrieved 2026-10-26)
- Started: 2016-04 (actual) (ClinicalTrials.gov record NCT05223361, source copy `cardio:ctgov-nct05223361-2022-02-03`, retrieved 2026-10-26)
- Primary completion: 2021-04-30 (actual) (ClinicalTrials.gov record NCT05223361, source copy `cardio:ctgov-nct05223361-2022-02-03`, retrieved 2026-10-26)
- Completion: 2021-11-30 (actual) (ClinicalTrials.gov record NCT05223361, source copy `cardio:ctgov-nct05223361-2022-02-03`, retrieved 2026-10-26)
- Countries: Iran (ClinicalTrials.gov record NCT05223361, source copy `cardio:ctgov-nct05223361-2022-02-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05223361-2022-02-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: Cardiopulmonary Bypass Prime Solution in Patients Undergoing Heart Valve Surgery
- Condition: Heart Valve Diseases
- Intervention (Drug): Six percent hydroxy ethyl starch 130/0.4
- Intervention (Drug): Ringer lactate
- Lead sponsor: Rajaie Cardiovascular Medical and Research Center
- Lead sponsor class: OTHER
- Collaborator: Heart Valve Disease Research Center
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Rajaie Cardiovascular Medical and Research Center (`cardio:org-rajaie-cardiovascular-medical-and-research-center`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Comparison of six percent hydroxyethyl starch 130/0.4 and ringer's lactate as priming solutions in patients undergoing isolated open heart valve surgery: A double-blind randomized controlled trial (`cardio:pubmed-38105566`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: e41addd37914c294037cacd61f8eb3eecfc3d479f230418d9f104e03eeae0c44
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
